Immediate Impact

2 by Nobel laureates 1 from Science/Nature 52 standout
Sub-graph 1 of 23

Citing Papers

Final Results From the Randomized Phase III ASCENT Clinical Trial in Metastatic Triple-Negative Breast Cancer and Association of Outcomes by Human Epidermal Growth Factor Receptor 2 and Trophoblast Cell Surface Antigen 2 Expression
2024 Standout
Datopotamab Deruxtecan in Advanced or Metastatic HR+/HER2– and Triple-Negative Breast Cancer: Results From the Phase I TROPION-PanTumor01 Study
2024 Standout
1 intermediate paper

Works of António Pêgo being referenced

Randomized Phase II Study of the Anti–Epidermal Growth Factor Receptor Monoclonal Antibody Cetuximab With Cisplatin Versus Cisplatin Alone in Patients With Metastatic Triple-Negative Breast Cancer
2013

Author Peers

Author Last Decade Papers Cites
António Pêgo 122 280 10 119 7 348
Jutta Groos 143 286 10 124 7 375
Marie-Pascale Graas 178 299 12 105 8 378
Zhong-Hua Wang 113 171 4 162 8 390
Lea Fuchs 65 305 20 81 5 392
Hobin Yang 177 179 7 120 12 340
A. Muti Abulafi 60 275 4 108 7 406
Claudia Capdevila 70 150 27 142 8 383
Germira Di Gioia 162 154 31 113 6 345
Amélie Petitprez 119 157 13 75 6 327
Marion Gilormini 81 136 21 92 7 323

All Works

Loading papers...

Rankless by CCL
2026